Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
2
×
national blog main
2
×
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
sanofi
american society of clinical oncology (asco)
amgen
anti-inflammatory drugs
arcturus therapeutics
avrobio
biotech
boulder/denver blog main
boulder/denver top stories
brexanolone
camp4 therapeutics
cancer
cancer immunotherapy
cholesterol
crispr therapeutics
crispr-cas9
data
deals
denali therapeutics
detroit blog main
detroit top stories
eidos therapeutics
estradiol
f-star gamma
fda
food and drug administration
gene editing
genmab
ido inhibitors
inclisiran
What
drug
2
×
key
2
×
aces
ahead
ambien
american
announced
annual
asco
attendees
attention
big
biotech
camp’s
cancer
cash
ceo
chicago
cholesterol
city
clinical
combinations
community’s
days
expanding
flexible
focus
home
inclisiran
kicks
lowering
meant
medco
medicine
medicines
meeting
nasdaq
oncology
oncology’s
open
Language
unset
Current search:
key
×
drug
×
" national blog main "
×
" life sciences "
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More